Event Group
Event Groups are part of the Adverse Events Module within the Results Section. They provide a way to organize and summarize adverse event data by grouping related events together.
Each Event Group typically represents a category or class of adverse events and includes statistical information such as the number of participants affected and at risk for different event types: deaths, serious events, and other events.
Event Group path is as follows:
Study -> Results Section -> Adverse Events Module -> Event Group
Event Group
Ignite Creation Date:
2025-12-25 @ 1:20 AM
Ignite Modification Date:
2025-12-25 @ 11:29 PM
NCT ID:
NCT00096993
Group ID:
EG000
Title:
Placebo + Gemcitabine
Description:
Participants received placebo intravenously on Day 1 of every 3 week cycle for up to 1 year (up to 17 treatment cycles). In addition, participants received gemcitabine 800 mg/m\^2 intravenously on Days 1 and 8 of every 3 week cycle for up to 1 year (up to 17 treatment cycles).
Placebo: Placebo was provided as a single-use formulation for infusion.
Gemcitabine: Gemcitabine was provided as a solution for infusion.
Deaths Number Affected:
None
Deaths Number At Risk:
None
Serious Number Affected:
40
Serious Number At Risk:
65
Other Number Affected:
65
Other Number At Risk:
65
Study:
NCT00096993
Results Section:
NCT00096993
Adverse Events Module:
NCT00096993